Preliminary Reliability and Validity of a New Time-Sensitive ADHD Symptom Scale in Adolescents with ADHD

References

• . Faraone SV, Sergeant J, Billberg C, Biederman J. The worldwide prevalence of ADHD: Is it an American condition? World Psychiatry. 2003; 2(2):104–113
   PubMedGoogle Scholar
• . Dulcan M. Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. American Academy of Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry. 1997; 36( suppl 10):85S–121S
   PubMed Web of Science ®Google Scholar
• . Brown TE. Attention-Deficit Disorders and Comorbidities in Children, Adolescents, and Adults. Washington, DC: American Psychiatric Press; 2000
   Google Scholar
• . Kessler RC, Adler L, Barkley R, . The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006; 163(4):716–723
   PubMed Web of Science ®Google Scholar
• . Barkley RA, Fischer M, Edelbrock CS, Smallish L. The adolescent outcome of hyperactive children diagnosed by research criteria: I. An 8-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry. 1990; 29(4):546–557
   PubMed Web of Science ®Google Scholar
• . Barkley RA, Anastopoulos AD, Guevremont DC, Fletcher KE. Adolescents with ADHD: Patterns of behavioral adjustment, academic functioning, and treatment utilization. J Am Acad Child Adolesc Psychiatry. 1991; 30(5):752–761
   PubMed Web of Science ®Google Scholar
• . Hinshaw SP. Attention-Deficits and Hyperactivity in Children. Thousand Oaks, CA: Sage Publications, Inc; 1994
   Google Scholar
• . Lahey BB, Applegate B, McBurnett K, . DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents. Am J Psychiatry. 1994; 151(11):1673–1685
   PubMed Web of Science ®Google Scholar
• . Mannuzza S, Klein RG. Adolescent and adult outcomes in attention-deficit/hyperactivity disorder. In: Quay HC, Hogan AE, eds. Handbook of Disruptive Behavior Disorders. New York, NY: Kluwer Academic/Plenum Publishers; 1999:279–294
   Google Scholar
• . Barkley RA, Murphy KR, Dupaul GI, Bush T. Driving in young adults with attention deficit hyperactivity disorder: Knowledge, performance, adverse outcomes, and the role of executive functioning. J Int Neuropsychol Soc. 2002; 8(5):655–672
   PubMed Web of Science ®Google Scholar
• . Cox DJ, Merkel RL, Penberthy JK, Kovatchev B, Hankin CS. Impact of methylphenidate delivery profiles on driving performance of adolescents with attention-deficit/hyperactivity disorder: A pilot study. J Am Acad Child Adolesc Psychiatry. 2004; 43(3):269–275
   PubMed Web of Science ®Google Scholar
• . Biederman J, Newcorn J, Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry. 1991; 148(5):564–577
   PubMed Web of Science ®Google Scholar
• . Biederman J, Faraone SV, Keenan K, . Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder. Patterns of comorbidity in probands and relatives in psychiatrically and pediatrically referred samples. Arch Gen Psychiatry. 1992; 49(9):728–738
   PubMed Web of Science ®Google Scholar
• . Biederman J, Faraone SV, Milberger S, . Is childhood oppositional defiant disorder a precursor to adolescent conduct disorder? Findings from a four-year follow-up study of children with ADHD. J Am Acad Child Adolesc Psychiatry. 1996; 35(9):1193–1204
   PubMed Web of Science ®Google Scholar
• . Wilens TE, Biederman J, Mick E, Faraone SV, Spencer T. Attention deficit hyperactivity disorder (ADHD) is associated with early onset substance use disorders. J Nerv Ment Dis. 1997; 185(8):475–482
   PubMed Web of Science ®Google Scholar
• . Milberger S, Biederman J, Faraone SV, Chen L, Jones J. ADHD is associated with early initiation of cigarette smoking in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1997; 36(1): 37–44
   PubMed Web of Science ®Google Scholar
• . American Academy of Pediatrics. Subcommittee on Attention-Deficit/Hyperactivity Disorder and Committee on Quality Improvement. Clinical practice guideline: Treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics. 2001; 108(4): 1033–1044
   PubMedGoogle Scholar
• . Pliszka SR, Crismon ML, Hughes CW, . The Texas Children's Medication Algorithm Project: Revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2006; 45(6):642–657
   PubMed Web of Science ®Google Scholar
• . A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry. 1999; 56(12):1073–1086
   PubMed Web of Science ®Google Scholar
• . Greenhill LL, Pliszka S, Dulcan MK, ; American Academy of Child and Adolescent Psychiatry. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry. 2002; 41( suppl 2): 26S–49S
   PubMed Web of Science ®Google Scholar
• . Wilens TE, Faraone SV, Biederman J, Gunawardene S. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics. 2003; 111(1):179–185
   PubMed Web of Science ®Google Scholar
• . Biederman J, Faraone SV. Attention-deficit hyperactivity disorder. Lancet. 2005; 366(9481):237–248
   PubMed Web of Science ®Google Scholar
• . Wilens TE, McBurnett K, Bukstein O, . Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med. 2006; 160(1):82–90
   PubMedGoogle Scholar
• . McGough JJ, McBurnett K, Bukstein O, . Once-daily OROS methylphenidate is safe and well tolerated in adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2006; 16(3):351–356
   PubMed Web of Science ®Google Scholar
• . Biederman J, Krishnan S, Zhang Y, McGough JJ, Findling RL. Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: A phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study. Clin Ther. 2007; 29(3):450–463
   PubMed Web of Science ®Google Scholar
• . Michelson D, Allen AJ, Busner J, . Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: A randomized, placebo-controlled study. Am J Psychiatry. 2002; 159(11):1896–1901
   PubMed Web of Science ®Google Scholar
• . Weiss M, Tannock R, Kratochvil C, . A randomized, placebo-controlled study of once-daily atomoxetine in the school setting in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2005; 44(7):647–655
   PubMed Web of Science ®Google Scholar
• . Wilens TE, Newcorn JH, Kratochvil CJ, . Long-term atomoxetine treatment in adolescents with attention-deficit/hyperactivity disorder. J Pediatr. 2006; 67(5):696–702
   Google Scholar
• . DuPaul GJ, George J, Power TJ, Anastopoulos AD. ADHD Rating Scale—IV: Checklists, Norms, and Clinical Interpretation. New York, NY: The Guilford Press; 1998
   Google Scholar
• . Conners CK. Conners' Rating Scale-Revised: Technical Manual. New York, NY: Multi-Health Systems, Inc.; 1997
   Google Scholar
• . Adler L, Cohen J. Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder. Psychiatr Clin North Am. 2004; 27(2): 187–201
   PubMed Web of Science ®Google Scholar
• . Spencer TJ, Adler LA, Weisler RH, Youcha SH. Triple-bead mixed amphetamine salts (SPD465), a novel, enhanced extended-release amphetamine formulation for the treatment of adults with ADHD: A randomized, double-blind, multicenter, placebo-controlled study. J Clin Psychiatr. 2008; 69(9):1437–1448
   PubMed Web of Science ®Google Scholar
• . American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000
   Google Scholar
• . Kaufman J, Birmaher B, Brent D, . Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997; 36(7):980–988
   PubMed Web of Science ®Google Scholar
• . Adler LA, Spencer T, Faraone SV, . Validity of pilot adult ADHD self-report scale (ASRS) to rate adult ADHD symptoms. Ann Clin Psychiatry. 2006; 18(3):145–148
   PubMedGoogle Scholar
• . Adler LA, Sitt DJ, Faraone SV, . Reliability and validity of the time-sensitive ADHD symptom scale (TASS) in adults. Presented at: 53rd annual meeting of the American Academy of Child and Adolescent Psychiatry; San Diego, CA; 2006
   Google Scholar
• . Adler LA, Shaw DM, Spencer TJ. Reliability and validity of the time-sensitive ADHD symptom scale (TASS) in adults. Compr Psychiatry. In press
   Google Scholar
• . Faries DE, Yalcin I, Harder D, Heiligenstein JH. Validation of the ADHD Rating Scale as a clinician administered and scored instrument. J Atten Disord. 2001; 5(2):107–115
   Google Scholar
• . Adler LA, Spencer T, Faraone SV, . Training raters to assess adult ADHD: Reliability of ratings. J Atten Disord. 2005; 8(3):121–126
   PubMedGoogle Scholar
• . Cronbach LJ. Coefficient alpha and the internal consistency of tests. Psychometrika. 1951; 16(3):297–334
   Web of Science ®Google Scholar
• . Hollingshead AB. Four Factor Index of Social Status. New Haven, CT: Yale University Press; 1975
   Google Scholar